Pitha Ian F

Patient Acceptance of Sustained Glaucoma Treatment Strategies.

Most glaucoma patients considered sustained drug-delivery modalities acceptable alternatives to IOP-lowering eye drops, but only when they were said to obviate surgery or demonstrate greater efficacy than eye drops.

The Mechanisms of Neuroprotection by Topical Rho Kinase Inhibition in Experimental Mouse Glaucoma and Optic Neuropathy.

Topical Rip reduced RGC loss in GL and ON crush, with suppression of ROCK signaling in the retina and ON.